BNP Paribas Financial Markets
AMRI

BNP Paribas Financial Markets’s Albany Molecular Research Inc AMRI Stock Holding History

BNP Paribas Financial Markets’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,044
Closed -$153K – 4361
2017
Q2 		$153K Buy
7,044
+2,895
+70% +$52.5K ﹤0.01% 2604
2017
Q1 		$58.2K Sell
4,149
-680
-14% -$11.1K ﹤0.01% 2690
2016
Q4 		$90.6K Buy
4,829
+1,569
+48% +$26.7K ﹤0.01% 2570
2016
Q3 		$53.8K Sell
3,260
-5,069
-61% -$75.1K ﹤0.01% 2403
2016
Q2 		$112K Buy
8,329
+4,475
+116% +$65.3K ﹤0.01% 2086
2016
Q1 		$58.9K Sell
3,854
-1,058
-22% -$16.6K ﹤0.01% 1955
2015
Q4 		$97.5K Sell
4,912
-340
-6% -$6.46K ﹤0.01% 2350
2015
Q3 		$91.5K Buy
5,252
+3,176
+153% +$64.7K ﹤0.01% 2449
2015
Q2 		$42K Buy
2,076
+1,526
+277% +$29.4K ﹤0.01% 2595
2015
Q1 		$9.68K Buy
+550
New +$9.37K ﹤0.01% 2763
2014
Q4 		– Sell
-1,400
Closed -$30.9K – 3776
2014
Q3 		$30.9K Buy
1,400
+1,370
+4,567% +$28.1K ﹤0.01% 2882
2014
Q2 		$604 Buy
+30
New +$508 ﹤0.01% 3556
2014
Q1 		– Sell
-301
Closed -$3.03K – 4058
2013
Q4 		$3.03K Buy
+301
New +$3.64K ﹤0.01% 3423

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

BNP Paribas Financial Markets's AMRI Position: Q3 2017 in Review

BNP Paribas Financial Markets sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 7,044 shares — an estimated $153K sold.

BNP Paribas Financial Markets first reported a position in AMRI in Q4 2013 and held it in 13 quarters. The position peaked at $153K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • BNP Paribas Financial Markets reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 7,044 Albany Molecular Research Inc shares in Q3 2017, an estimated $153K.
  • BNP Paribas Financial Markets first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 13 quarters.
  • BNP Paribas Financial Markets's Albany Molecular Research Inc position peaked at $153K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2017, filed 3 Nov 2017.